Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Jupiter Neurosciences, Inc. (JUNS) since 2025 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Jupiter Neurosciences, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1679628.
Total stock buying since 2025: $14,274.
Total stock sales since 2025: $0.
Total stock option exercises since 2025: $0.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2026 | 0 | $0 | 0 | $0 | 225,000 | $0 |
| 2025 | 13,966 | $14,274 | 0 | $0 | 2,497,098 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2026-03 | 0 | $0 | 0 | $0 | 225,000 | $0 |
| 2025-07 | 4,350 | $4,425 | 0 | $0 | 0 | $0 |
| 2025-06 | 9,616 | $9,849 | 0 | $0 | 2,464,567 | $0 |
| 2025-01 | 0 | $0 | 0 | $0 | 32,531 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2026-03-02 | Hayward Marshall A. (Chief Scientific Officer) | Option Ex | 225,000 | .00 | 0 |
| 2025-07-01 | Silva Alison D. (Pres + Chief Business Officer) | Buy | 750 | 1.03 | 772 |
| 2025-07-01 | Rosen Christer (CEO and Chairman) | Buy | 3,600 | 1.01 | 3,653 |
| 2025-06-30 | Silva Alison D. (Pres + Chief Business Officer) | Buy | 950 | 1.03 | 979 |
| 2025-06-30 | Rosen Christer (CEO and Chairman) | Buy | 7,650 | 1.02 | 7,818 |
| 2025-06-27 | Silva Alison D. (Pres + Chief Business Officer) | Buy | 850 | 1.03 | 877 |
| 2025-06-27 | Rosen Christer (CEO and Chairman) | Buy | 166 | 1.06 | 175 |
| 2025-06-02 | Rosen Alexander Gustaf Erik (Chief Administrative Officer) | Option Ex | 261,161 | .00 | 0 |
| 2025-06-02 | Silva Alison D. (Pres + Chief Business Officer) | Option Ex | 110,227 | .00 | 0 |
| 2025-06-02 | Hayward Marshall A. (Chief Scientific Officer) | Option Ex | 789,195 | .00 | 0 |
| 2025-06-02 | Elmasri Saleem (CFO and Secretary) | Option Ex | 66,293 | .00 | 0 |
| 2025-06-02 | Kampf Julie B. | Option Ex | 82,875 | .00 | 0 |
| 2025-06-02 | Weis Holger | Option Ex | 85,800 | .00 | 0 |
| 2025-06-02 | Hemmerly Nicholas H. | Option Ex | 95,550 | .00 | 0 |
| 2025-06-02 | Rosen Christer (CEO and Chairman) | Option Ex | 973,466 | .00 | 0 |
| 2025-01-22 | Brady Allison W | Option Ex | 21,750 | .00 | 0 |
| 2025-01-22 | Weis Holger | Option Ex | 10,781 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises of JUNS listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Jupiter Neurosciences, Inc. (symbol JUNS, CIK number 1679628) see the Securities and Exchange Commission (SEC) website.